Skip to content Skip to sidebar Skip to footer
Ta Khoa project
Investors are wrong about Blackstone Minerals’ (ASX:BSX) Ta Khoa project, but here’s why big things are coming in the next 6 months
Blackstone Minerals (ASX:BSX) and its Ta Khoa project have been misperceived by investors. You'd be forgiven for thinking BSX is an exploration company first with processing and refining facilities as a side-hustle. In reality, it is a processing and refining company first, and while it has an underground mine, this mine will provide a tiny…
Chemist Warehouse Sigma merger
The $8.8bn Chemist Warehouse Sigma merger is finally going ahead with the ACCC not killing it off
Nearly a year since the $8.8bn Chemist Warehouse Sigma merger was unveiled, it seems we finally got a definitive answer as to whether or not it will go ahead. The ACCC investigated the deal and there was the risk of it blocking the deal if it reckons it will lessen competition. After all, it raised…
Aristocrat Leisure
Aristocrat Leisure (ASX:ALL) is one of ASX’s largest tech stocks that just happens to be in gaming
Why has Aristocrat Leisure (ASX:ALL) succeeded where so many other gambling stocks have struggled? This company is up nearly 55% in the last 12 months and 96% in the last 5 years. Many other gaming stocks have struggled due to cost of living pressures, new restrictions and (in the case of some stocks) pecuniary penalties.…
Recce's Phase II ABSSSI Clinical Trial
Recce’s Phase 2 ABSSSI Clinical Trial is on Track and Producing Outstanding Results
There are encouraging signs from Recce Pharmaceuticals' (ASX:RCE) Phase 2 ABSSSI Clinical Trial (Acute Bacterial Skin and Skin Structure Infections). The trial, is nearing completion, but the results to date have led to a Non-Data Safety Monitoring Board reviewing the trial unanimously recommending it continue. Not only have there been no serious adverse events, but all…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here